glp 1 gip receptor agonist Dual GIP/GLP-1 agonists: New advances for treating type-2 diabetes Mechanisms of action and therapeutic

Tirzepatide is available as two brand-name drugs: is indicated to treat type 2 diabetes in adults

doi: 10.1155/2021/9923537

In diabetic mice, semaglutide alleviated anxiety- and depression-like behaviors and improved cognitive performance via modulation of the microbiota-gut-brain axis ( In summary, accumulating evidence supports the potential of GLP-1RAs in treating neurodegenerative and psychosocial disorders

GLP-1 Receptor Agonist Market Insights, By Drug Class: Liraglutide Contributes the Highest Share of the Market Owing to its Effectiveness and Superior Efficacy In terms of drug type, liraglutide is expected to contribute 26.5% share of the market in 2026, as its once-daily subcutaneous administration provides consistent glycemic control throughout the day

Adequate protein and micronutrient intake can significantly reduce the risk

Considering the significantly elevated expression levels of GLP-1R in diabetic patients, it is hypothesized that administration of GLP-1R agonists may elevate the risk of breast cancer progression in these patients, thus necessitating particular caution in clinical management [101]